Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|March 11, 2021
HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in childrenRebecca A Porritt, Lisa Paschold, Magali Noval Rivas, et al.
Clinical & Translational Immunology|September 6, 2021
Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohortsDonjete Simnica, Christoph Schultheiß, Malte Mohme, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
BMC Cancer|June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
Blood|April 2, 2016
A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myelomaAneta Schieferdecker, Anna Oberle, Benjamin Thiele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating LymphocytesMalte Mohme, Simon Schliffke, Cecile L Maire, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Cancers|March 25, 2022
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)Sabrina Jotschke, Susann Schulze, Nadja Jaekel, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|March 11, 2021
HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in childrenRebecca A Porritt, Lisa Paschold, Magali Noval Rivas, et al.
Clinical & Translational Immunology|September 6, 2021
Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohortsDonjete Simnica, Christoph Schultheiß, Malte Mohme, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
BMC Cancer|June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
Blood|April 2, 2016
A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myelomaAneta Schieferdecker, Anna Oberle, Benjamin Thiele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating LymphocytesMalte Mohme, Simon Schliffke, Cecile L Maire, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Cancers|March 25, 2022
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)Sabrina Jotschke, Susann Schulze, Nadja Jaekel, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Pageof 15